KINIKSA PHARMACEUTICALS (UK), LTD.
Company number 11716038
- Company Overview for KINIKSA PHARMACEUTICALS (UK), LTD. (11716038)
- Filing history for KINIKSA PHARMACEUTICALS (UK), LTD. (11716038)
- People for KINIKSA PHARMACEUTICALS (UK), LTD. (11716038)
- Registers for KINIKSA PHARMACEUTICALS (UK), LTD. (11716038)
- More for KINIKSA PHARMACEUTICALS (UK), LTD. (11716038)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
06 Oct 2024 | AA | Full accounts made up to 31 December 2023 | |
20 Aug 2024 | TM01 | Termination of appointment of Ross Michael Moat as a director on 1 August 2024 | |
02 Jul 2024 | PSC07 | Cessation of Kiniksa Pharmaceuticals, Ltd. as a person with significant control on 27 June 2024 | |
02 Jul 2024 | PSC02 | Notification of Kiniksa Pharmaceuticals International, Plc as a person with significant control on 27 June 2024 | |
17 May 2024 | SH19 |
Statement of capital on 17 May 2024
|
|
17 May 2024 | SH20 | Statement by Directors | |
17 May 2024 | CAP-SS | Solvency Statement dated 12/05/24 | |
17 May 2024 | RESOLUTIONS |
Resolutions
|
|
12 Jan 2024 | CS01 | Confirmation statement made on 5 December 2023 with no updates | |
02 Jan 2024 | RESOLUTIONS |
Resolutions
|
|
04 Dec 2023 | SH19 |
Statement of capital on 4 December 2023
|
|
04 Dec 2023 | RESOLUTIONS |
Resolutions
|
|
04 Dec 2023 | CAP-SS | Solvency Statement dated 20/11/23 | |
04 Dec 2023 | SH20 | Statement by Directors | |
12 Oct 2023 | AA | Full accounts made up to 31 December 2022 | |
22 Aug 2023 | RP04SH01 |
Second filing of a statement of capital following an allotment of shares on 11 October 2022
|
|
22 Aug 2023 | RP04SH01 |
Second filing of a statement of capital following an allotment of shares on 21 February 2022
|
|
17 Mar 2023 | TM01 | Termination of appointment of Sanjiv Patel as a director on 17 February 2023 | |
07 Jan 2023 | AA | Accounts for a small company made up to 31 December 2021 | |
05 Jan 2023 | CS01 | Confirmation statement made on 5 December 2022 with updates | |
22 Dec 2022 | SH01 |
Statement of capital following an allotment of shares on 11 October 2022
|
|
22 Dec 2022 | SH01 |
Statement of capital following an allotment of shares on 21 February 2022
|
|
10 Mar 2022 | AD03 | Register(s) moved to registered inspection location Suite 2 First Floor 10 Temple Back Bristol BS1 6FL | |
10 Mar 2022 | AD02 | Register inspection address has been changed to Suite 2 First Floor 10 Temple Back Bristol BS1 6FL | |
20 Dec 2021 | CS01 | Confirmation statement made on 5 December 2021 with updates |